摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4'-Hydroxybiphenyl-4-carboxylic acid | 203718-39-2

中文名称
——
中文别名
——
英文名称
4'-Hydroxybiphenyl-4-carboxylic acid
英文别名
3'-nitro-4'-hydroxybiphenyl-4-carboxylic acid;4-(4-Carboxyphenyl)-2-nitrophenol;4-(4-hydroxy-3-nitrophenyl)benzoic acid
4'-Hydroxybiphenyl-4-carboxylic acid化学式
CAS
203718-39-2
化学式
C13H9NO5
mdl
——
分子量
259.218
InChiKey
YFLVBXPEJDUFQI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    19
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    103
  • 氢给体数:
    2
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    4'-Hydroxybiphenyl-4-carboxylic acid4-二甲氨基吡啶氢氧化钾N,N'-二环己基碳二亚胺 、 potassium iodide 作用下, 以 二氯甲烷 为溶剂, 反应 30.0h, 生成
    参考文献:
    名称:
    Effects of nitro substituents on the properties of a ferroelectric liquid crystalline side chain polysiloxane
    摘要:
    本文描述了具有侧链硝基取代基和介晶核心的手性液晶侧链聚硅氧烷的合成。研究并比较了取代基及其位置对相行为和电光性质的影响。侧链前体及液晶聚合物的相行为受到侧向硝基的强烈影响。讨论了在层状A相和C*相中各取代基位置的性质。一种侧链前体表现出约700 nC cm–2的非常大自发极化。
    DOI:
    10.1039/a704918h
  • 作为产物:
    描述:
    4'-methoxy-3'-nitro-biphenyl-4-carboxylic acid 在 氢溴酸溶剂黄146 作用下, 生成 4'-Hydroxybiphenyl-4-carboxylic acid
    参考文献:
    名称:
    Effects of nitro substituents on the properties of a ferroelectric liquid crystalline side chain polysiloxane
    摘要:
    本文描述了具有侧链硝基取代基和介晶核心的手性液晶侧链聚硅氧烷的合成。研究并比较了取代基及其位置对相行为和电光性质的影响。侧链前体及液晶聚合物的相行为受到侧向硝基的强烈影响。讨论了在层状A相和C*相中各取代基位置的性质。一种侧链前体表现出约700 nC cm–2的非常大自发极化。
    DOI:
    10.1039/a704918h
点击查看最新优质反应信息

文献信息

  • New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
    申请人:Boehringer Ingelheim International GmbH
    公开号:US20040242572A1
    公开(公告)日:2004-12-02
    The present invention relates to carboxamide compounds of general formula I 1 wherein the groups and residues A, B, W, X, Y, Z, R 1 , R 2 , R 3 and k have the meanings given in claim 1. Moreover the invention relates to process for preparing the above mentioned carboxamides as well as pharmaceutical compositions containing at least one carboxamide according to the invention. In view of their MCH-receptor antagonistic activity the pharmaceutical compositions according to the invention are suitable for the treatment of metabolic disorders and/or eating disorders, particularly obesity, bulimia, anorexia, hyperphagia and diabetes.
    本发明涉及具有通式I的羧酰胺化合物 1 其中,A、B、W、X、Y、Z、R 1 、R 2 、R 3 和k的含义如权利要求1中所述。此外,本发明还涉及制备上述羧酰胺的方法以及含有至少一种根据本发明的羧酰胺的药物组合物。由于它们对MCH受体的拮抗活性,根据本发明的药物组合物适合用于治疗代谢紊乱和/或饮食紊乱,特别是肥胖症、厌食症、暴食症、糖尿病。
  • Thrombopoietin mimetics
    申请人:——
    公开号:US20040019190A1
    公开(公告)日:2004-01-29
    Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy- 1 -azobenzene derivative.
    发明了非肽类TPO类似物。还发明了用于制备目前发明的化合物的新工艺和中间体。还发明了一种治疗血小板减少症的方法,包括给予需要的哺乳动物,包括人类,有效量的选择性羟基-1-偶氮苯衍生物。
  • THROMBOPOIETIN MIMETICS
    申请人:Duffy Kevin J.
    公开号:US20130078213A1
    公开(公告)日:2013-03-28
    Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative.
    本发明涉及非肽类TPO类似物的发明。本发明还涉及用于制备目前发明的化合物的新型过程和中间体。本发明还涉及一种治疗血小板减少症的方法,包括在需要的哺乳动物(包括人类)中给予所选的羟基-1-偶氮苯衍生物的有效量。
  • Phase Transitions of 4‘-<i>n</i>-Hexacosyloxy-3‘-nitrobiphenyl-4-carboxylic Acid (ANBC-26):  Two Types of Thermotropic Cubic Phases
    作者:Shoichi Kutsumizu、Tatsuya Ichikawa、Minoru Yamada、Shuichi Nojima、Shinichi Yano
    DOI:10.1021/jp0018652
    日期:2000.11.1
    The phase transitions of 4'-n-hexacosyloxy-3'-nitrobiphenyl-4-carboxylic acid (ANBC-26, where "26" indicates the number of carbon atoms in the alkoxy group) were investigated by differential scanning calorimetric (DSC), polarizing optical microscopic, and X-ray diffraction (XRD) measurements. ANBC-26 is a new liquid crystalline material which exhibits successively two types of three-dimensionally ordered cubic mesophases on heating; the low-temperature cubic (CubI) phase has a space group of Im3m, and the high-temperature one (CubII phase) is of Ia3d type, identical with the cubic phase of shorter alkoxy chain homologues such as ANBC-16, and a cubic-cubic phase transition occurs at 435 K on DSC, Reversibility of the transitions between them was studied and the structures of those mesophases are discussed. The transformation from a one-dimensionally ordered smectic C (SmC) to the CubI phase and to the CubII phase can be interpreted qualitatively in terms of the increased curvature of the interface. The structured liquid Il phase, an intermediate phase between the CubII and a true isotropic liquid I-2 phases, has been also studied, indicating that this phase could be characterized by Ornstein-Zernike type short-range fluctuation, which means the presence of molecular clusters consisting of several ANBC-26 dimers in the temperature region.
  • EP1294378A4
    申请人:——
    公开号:EP1294378A4
    公开(公告)日:2004-01-28
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐